Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Stomach cancer

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    307 result(s) found for: Stomach cancer. Displaying page 1 of 16.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2011-004405-25 Sponsor Protocol Number: HIPEC_Stomach Start Date*: 2012-03-01
    Sponsor Name:University Hospital Tübingen
    Full Title: Study for prevention of peritoneal carcinomatosis in patients with stomach cancer
    Medical condition: Reducing the risk of peritoneal carcinomatosis in patients with stomach cancer with following treatment: gastrectomy incl. HIPEC vs. gastrectomy excl. HIPEC
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10017758 Gastric cancer PT
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10068069 Peritoneal carcinomatosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-022164-12 Sponsor Protocol Number: TOG301 Start Date*: 2012-01-23
    Sponsor Name:Genta Incorporated
    Full Title: A randomized, double-blind study of capecitabine plus tesetaxel versus capecitabine plus placebo as second-line therapy in subjects with gastric cancer
    Medical condition: Histologically or cytologically confirmed gastric carcinoma, including gastric or gastroesophageal-junction adenocarcinoma
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10017760 Gastric cancer NOS LLT
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10017758 Gastric cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prohibited by CA)
    Trial results: (No results available)
    EudraCT Number: 2012-002321-30 Sponsor Protocol Number: 12.01 Start Date*: 2012-11-01
    Sponsor Name:Odense University Hospital
    Full Title: Randomized phase II trial with irinotecan as monotherapy compared to irinotecan and bevacizumab (BevIri) for patietns with platinum resistant non-resectable esophagus-, cardia or gastric cancer
    Medical condition: Patients with esophagus or gastric cancer and who are platinum resistant and non-resectabel
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10017758 Gastric cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2010-020189-37 Sponsor Protocol Number: IRST151.01 Start Date*: 2010-08-13
    Sponsor Name:ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
    Full Title: A randomised phase II study of pre-operative or peri-operative docetaxel, oxaliplatin, capecitabine (DOX) regimen in patients with locally advanced resectable gastric cancer
    Medical condition: Patient with potentially resectable adenocarcinoma of the stomach
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10017758 Gastric cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-022699-30 Sponsor Protocol Number: B-DOCT Start Date*: 2011-01-19
    Sponsor Name:Nederlands Kanker Instutuut-Antonie van Leeuwenhoek Ziekenhuis
    Full Title: Phase II Study of Docetaxel, Oxaliplatin, Capecitabine with Bevacizumab and Trastuzumab in case of human epidermal growth factor receptor 2 (HER2)-positivity in Patients with Locally Advanced or Me...
    Medical condition: Locally Advanced or Metastatic Gastric Cancer or Adenocarcinoma of the Gastro-oesophageal Junction
    Disease: Version SOC Term Classification Code Term Level
    12.1 10063916 Metastatic gastric cancer PT
    12.1 10017758 Gastric cancer LLT
    12.1 10066896 HER-2 positive gastric cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-005046-37 Sponsor Protocol Number: COUGAR-02 Start Date*: 2007-12-28
    Sponsor Name:Cambridge University Hospitals NHS Foundation Trust
    Full Title: COUGAR-02: A randomised phase III study of docetaxel vs active symptom control in patients with relapsed oesophago-gastric adenocarcinoma
    Medical condition: Advanced oesophago-gastric cancer which has previously been treated with a platinum and fluoropyrimidine based combination
    Disease: Version SOC Term Classification Code Term Level
    13.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10017758 Gastric cancer PT
    13.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10001173 Adenocarcinoma of esophagus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-004072-37 Sponsor Protocol Number: 77/2004/O/Sper Start Date*: 2004-09-09
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: CETUXIMAB AND FOLFIRI AS FIRST-LINE TREATMENT OF LOCALLY ADVANCED AND METASTATIC GASTRIC CANCER
    Medical condition: Locally advanced or metastatic non-resectable gastric cancer stomach or gastro-esophageal junction
    Disease: Version SOC Term Classification Code Term Level
    6.1 10017758 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-001500-36 Sponsor Protocol Number: 27/2006/O/Sper Start Date*: 2006-05-12
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: Radio-controlled surgery RGS in the gastric carcinoma locally advanced subordinate to neoadiuvante medical therapy. Clinical study of feasibilities and correlation with the traditional methodica...
    Medical condition: carcinoma of the locally advanced stomach
    Disease: Version SOC Term Classification Code Term Level
    6.1 10017758 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-006088-22 Sponsor Protocol Number: Gastripec-I Start Date*: 2011-03-28
    Sponsor Name:Klinik für Chirurgie, Charité Campus Virchow-Klinikum
    Full Title: Prospective multicenter phase III clinical trial using cytoreductive surgery with hyperthermic intraoperative chemotherapy (HIPEC) after preoperative chemotherapy in patients with peritoneal carc...
    Medical condition: Peritoneal carcinomatosis of gastric cancer incl. adenocarcinoma of the esophagogastreal junction
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004864 10042080 Stomach cancer LLT
    20.0 100000004864 10042081 Stomach cancer in situ LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-004512-43 Sponsor Protocol Number: ML20777 Start Date*: 2007-01-29
    Sponsor Name:Roche Farma, S.A.
    Full Title: Estudio Fase II abierto de Capecitabina (Xeloda®) como fluoropirimidina de elección en combinación con quimioterapia en pacientes con cáncer gástrico Avanzado y/o Metastático susceptibles de ser tr...
    Medical condition: Capecitabine in combination with chemotherapy in patients with advanced and/or metastatic gastric cancer suitable to be treated with a fluoropirimidine based regimen to assess the safety profile sp...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10017758 Gastric cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2008-006168-12 Sponsor Protocol Number: 08.14 Start Date*: 2008-11-17
    Sponsor Name:Odense University Hospital
    Full Title: Phase II trial with Cetuximab and Irinotecan (CetIri) for patients with platinum resistant esofagus- or gastric cancer
    Medical condition: Patients with esofagus- and gastric cancer
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017758 Gastric cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2008-004223-27 Sponsor Protocol Number: GEMCAD-0802 Start Date*: 2008-10-29
    Sponsor Name:GEMCAD
    Full Title: Estudio fase II, de la combinación de Oxaliplatino y Sorafenib en pacientes con Adenocarcinoma gástrico o de la unión gastroesofágica localmente avanzado o metastásico, en progresión tras un esque...
    Medical condition: CANCER GASTRICO
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017758 Gastric cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-004504-39 Sponsor Protocol Number: AIO STO-0601 Start Date*: 2008-06-24
    Sponsor Name:Martin-Luther-Universität Halle-Wittenberg, vertreten durch den Kanzler
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    14.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10017758 Gastric cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-005464-92 Sponsor Protocol Number: DOCOX-C-00082 Start Date*: 2006-06-07
    Sponsor Name:Sanofi-aventis groupe
    Full Title: Estudio randomizado de fase II de Docetaxel en combinación con Oxaliplatino con o sin 5-FU o Capecitabina, en cáncer gástrico metastásico o en recurrencia local que no haya sido tratado previamente...
    Medical condition: Cáncer gástrico metastásico o en recurrencia local que no haya sido tratado previamente para la enfermedad avanzada con quimioterapia
    Disease: Version SOC Term Classification Code Term Level
    8.1 10017758
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) BE (Completed) GB (Completed) DE (Completed) HU (Completed) PT (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2016-002331-16 Sponsor Protocol Number: PRODIGE51 Start Date*: 2016-10-03
    Sponsor Name:Fédération Francophone de Cancérologie Digestive
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004864 10042080 Stomach cancer LLT
    19.0 100000004864 10042089 Stomach cancer stage IV without metastases LLT
    19.0 100000004864 10042088 Stomach cancer stage IV with metastases LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2008-006544-20 Sponsor Protocol Number: CRAD001R2301 Start Date*: 2009-07-06
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, double-blind, multi-center phase III study comparing everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in patients with advanced gastric cancer af...
    Medical condition: advanced gastric cancer
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017758 Gastric cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) BE (Completed) DE (Completed) GB (Completed) FR (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-016468-35 Sponsor Protocol Number: D8480C00067 Start Date*: 2016-03-29
    Sponsor Name:AstraZeneca AB
    Full Title: A randomised, double-blind, phase III efficacy and safety study of cediranib (RECENTIN™ ) when added to cisplatin plus a fluoropyrimidine, compared with cisplatin plus a fluoropyrimidine alone, in ...
    Medical condition: Gastric cancer
    Disease: Version SOC Term Classification Code Term Level
    12.1 10017758 Gastric cancer LLT
    12.1 10017760 Gastric cancer NOS LLT
    12.1 10017766 Gastric cancer stage IV NOS LLT
    12.1 10017767 Gastric cancer stage IV with metastases LLT
    12.1 10017768 Gastric cancer stage IV without metastases LLT
    12.1 10061967 Gastric cancer stage IV LLT
    12.1 10063916 Metastatic gastric cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GR (Completed) HU (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-001503-10 Sponsor Protocol Number: 29/2006/O/Sper Start Date*: 2006-05-12
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: Technology of the radioisotopes for the intra-operative identification of the sentinel node in the premature gastric cancer. Clinical study of feasibility in order to improve the treatment and prog...
    Medical condition: gastric cancer
    Disease: Version SOC Term Classification Code Term Level
    6.1 10061968 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-004130-32 Sponsor Protocol Number: CRITICS Start Date*: 2006-10-17
    Sponsor Name:NKI/Antoni van Leeuwenhoek Ziekenhuis
    Full Title: A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer (CRITICS-study: ChemoRadi...
    Medical condition: Resectable gastric cancer
    Disease: Version SOC Term Classification Code Term Level
    8.1 10017758 Gastric cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing) SE (Completed) DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-014895-23 Sponsor Protocol Number: #0038 Start Date*: 2013-02-01
    Sponsor Name:Universitätsklinikum Erlangen
    Full Title: Phase II clinical trial of a sequential therapy involving the FLOT regiment in palliative first-line treatment followed by AIO plus irinotecan in second-line treatment combined with supportive pare...
    Medical condition: Advanced non-resectable adenocarcinoma of the stomach and the gastro-oesophageal junction
    Disease: Version SOC Term Classification Code Term Level
    15.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10017758 Gastric cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 09 18:21:59 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA